Vitamin D2 Supplements May Quietly Deplete Your Body's More Powerful D3
New research finds D2 supplements can lower D3 levels and may lack D3's unique immune-boosting effects, prompting calls to rethink supplementation.
Summary
A new meta-analysis from the University of Surrey found that taking vitamin D2 supplements can actually reduce the body's levels of vitamin D3 — the form naturally produced from sunlight and considered more effective at raising overall vitamin D status. Researchers analyzed data from multiple randomized controlled trials and found D3 levels often dropped below those seen in control groups not taking any supplement. Separate research also shows D3 uniquely activates type I interferon signaling, a frontline immune defense against viruses and bacteria — an effect D2 does not appear to share. Scientists are now urging a rethink of supplement recommendations, suggesting D3 should be the preferred choice for most people, with plant-based D3 options made more widely available for those avoiding animal-derived products.
Detailed Summary
Millions of people take vitamin D supplements to support bone strength and immune health, especially during winter months when sunlight exposure is insufficient. But new research suggests that choosing the wrong form of vitamin D could quietly undermine your body's own vitamin D stores.
A meta-analysis published in Nutrition Reviews, led by researchers at the University of Surrey, John Innes Centre, and Quadram Institute Bioscience, found that vitamin D2 supplementation consistently reduced circulating vitamin D3 levels compared to controls. In many trials reviewed, D3 concentrations in D2 supplement users fell below those seen in people taking no supplement at all — a finding researchers describe as a previously unknown and concerning effect.
The two forms are not interchangeable. Vitamin D3 is the form the body naturally synthesizes from UVB sunlight and uses most efficiently to raise total vitamin D status. Vitamin D2, derived primarily from plant and fungal sources, has long been used in supplements and fortified foods but appears less effective at sustaining vitamin D levels and may actively displace D3.
Beyond blood levels, D3 appears to have a functionally distinct role in immunity. Complementary research published in Frontiers in Immunology showed that D3, but not D2, stimulates type I interferon signaling — a critical early immune response that helps the body detect and fight off bacterial and viral infections. This immune distinction adds another layer of reason to prefer D3.
The practical implication is clear: for most individuals, vitamin D3 supplements are likely the better choice. Researchers also highlighted the need to expand access to plant-based D3 (typically derived from lichen), which would allow vegans and vegetarians to benefit from D3 without relying on animal-sourced options. Further trials are still needed to fully establish whether D3 should become the universal first-line recommendation.
Key Findings
- Vitamin D2 supplements can reduce circulating D3 levels, sometimes below levels seen in non-supplementing controls.
- Vitamin D3 more effectively raises overall vitamin D status than D2 in randomized controlled trials.
- D3 activates type I interferon immune signaling against viruses and bacteria; D2 does not appear to share this effect.
- Researchers recommend D3 as the preferred supplement form for most people, pending individual considerations.
- Plant-based D3 from lichen should be made more accessible for those avoiding animal-derived supplements.
Methodology
This article summarizes a peer-reviewed meta-analysis published in Nutrition Reviews and supporting immunology research published in Frontiers in Immunology, both from credible UK academic institutions. The evidence basis includes pooled data from multiple randomized controlled trials, which represents a relatively high standard of evidence. The news report is from ScienceDaily and accurately reflects the researchers' conclusions without apparent exaggeration.
Study Limitations
The meta-analysis relies on pooled trial data with likely variability in dosing, duration, and population demographics across studies. The immune signaling findings are based on mechanistic research and may not yet translate to confirmed clinical outcomes like reduced infection rates. Primary papers in Nutrition Reviews and Frontiers in Immunology should be consulted for full methodology and effect sizes.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
